POM-V Prescription Required

BioEquin EHV Emulsion for Injection for Horses

Active ingredient: Equine herpesvirus 1

Form

Injection

Species

Horses

Manufacturer

Bioveta, a.s.

VMD MA No.

46608/5002

What it's used for

For active immunization of horses to reduce clinical signs and to reduce virus excretion during respiratory disease caused by equine herpesvirus type 1 (EH...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Equine herpesvirus 1

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

BioEquin EHV Emulsion for Injection for Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunization of horses to reduce clinical signs and to reduce virus excretion
during respiratory disease caused by equine herpesvirus type 1 (EHV-1) infections.
Onset of immunity: 2 weeks after the second vaccine injection
Duration of immunity has only been demonstrated after the administration of three
vaccine injections (see section 4.9): 6 months after the 3rd vaccine injection.
For active immunisation of pregnant mares to reduce the occurence of abortions
caused by equine herpesvirus type 1 (EHV-1) infections.
Onset immunity: 3 weeks after the 3rd vaccine injection during gestation
Duration of immunity: until the end of pregnancy.

Revised: March 2025
AN: 03754/2024

For intramuscular use: administer the vaccine dose (1 ml ) by deep
intramuscularinjection.
Before use, allow the vaccine to reach a temperature of 15-25°C.
Shake well before use.
Vaccination schedule - Primary vaccination:
The basic immunisation schedule consists of three vaccine injections : the first injection
from the age of 6 months; the second injection 4 weeks later, and the third injection 3
months after the second dose.
Revaccination:
Administer one dose of vaccine 6 months after completion of the primary vaccination
schedule, and thereafter every 6 months.
Vaccination of pregnant mares:
To reduce the incidence of abortions, administer one dose of the vaccine in the second
month after mating, one dose in the fifth or sixth month of pregnancy, and one dose in
the ninth month of pregnancy. The three dose vaccination scheme should be repeated for
subsequent pregnancies.

None.

The following was reported based on post-marketing surveillance experience:
Temporary temperature increases (at max. 40°C for 4 days) are very common after
vaccination. The development of local reactions that may reach up to 5x10 cm diameter

Revised: March 2025
AN: 03754/2024
are rare and persist for a maximum of 5 days. Anaphylactic reaction is very
rare.Symptomatic treatment should be provided.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals displaying adverse reaction(s) during the
course of one treatment)
- common (more than 1 but less than 10 animals in 100 animals)
- uncommon (more than 1 but less than 10 animals in 1,000 animals)
- rare (more than 1 but less than 10 animals in 10,000 animals)
- very rare (less than 1 animal in 10,000 animals, including isolated reports).

In order to reduce the infection pressure, all horses on the same premises should be
vaccinated. Before transfer of horses to other herds or stables, or before races,
vaccination should be performed allowing for at least 14 days for onset of
immunity.Before inclusion in a herd, horses should be vaccinated and kept in
quarantine until onset of immunity is reached. Sick horses with signs of a respiratory
disease should be isolated from healthy animals.
Vaccinate healthy animals only.

Special precautions for use in animals
None.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
In case of accidental self-injection seek medical advice immediately and show the
package leaflet or label to the physician.
To the user:
This veterinary medicinal product contains non-mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt medical
attention is not given. If you are accidentally injected with this veterinary medicinal
product, seek prompt medical advice even if only a very small amount is injected and
take the package leaflet with you. If pain persists for more than 12 hours after medical
examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains non-mineral oil. Even if small amounts have
been injected, accidental injection with this product can cause intense swelling, which
may, for example, result in ischaemic necrosis and even the loss of a digit. Expert,
PROMPT, surgical attention is required and may necessitate early incision and
irrigation of the injected area, especially where there is involvement of finger pulp or
tendon.

No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product. A decision to use this vaccine before or after any
other veterinary medicinal product therefore needs to be made on a case by case basis.

Store in a refrigerator (2°C - 8°C).
Protect from light.

Zero days.

Revised: March 2025
AN: 03754/2024
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Inactivated viral vaccines for horses
ATC vet code: QI05AA05
For active immunization against equine herpesvirus.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.